In this issue:
Immune responses following SARS-CoV-2 mRNA vaccination in MS patients on anti-CD20 therapy
Effects of high-and low-efficacy therapy in SPMS
AHSCT in active MS
Long-term analysis of patients with benign MS
Hospital-diagnosed infections before age 20 and risk of MS
CSF OCMB with relapsing MS and long-term disability
Clinical features and treatment of BCS
Clinical significance of a single CSF immunoglobulin band
Deep learning for the differentiation of solitary and multiple cerebral GBM, lymphoma, and TDL
Distinct clinico-radiologic signatures between NMOSD and MS
Please login below to download this issue (PDF)